Out Foxing Bcr-Abl

被引：0

作者：

Claxton, David F. ^{[1
]}

机构：

[1] Penn State Coll Med, Dept Med, Div Hematol Oncol, Hershey, PA USA

来源：

CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 08期

关键词：

Forkhead; Bcr-abl; leukemia; bortezomib; FoxO3; apoptosis; hematopoiesis; INHIBITION; APOPTOSIS; LEUKEMIA; PHASE-2;

D O I：

10.4161/cbt.11.8.15152

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：769 / 770

页数：2

共 6 条

[1] Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOX03a transcription factor [J].

Ghaffari, S ;

Jagani, Z ;

Kitidis, C ;

Lodish, HF ;

Khosravi-Far, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6523-6528

[2] Many forks in the path: cycling with FoxO [J].

Ho, K. K. ;

Myatt, S. S. ;

Lam, E. W-F .

ONCOGENE, 2008, 27 (16) :2300-2311

[3] Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL-Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors [J].

Jagani, Zainab ;

Song, Keli ;

Kutok, Jeffery L. ;

Dewar, M. Rajan ;

Melet, Armelle ;

Santos, Tanya ;

Grassian, Alexandra ;

Ghaffari, Saghi ;

Wu, Catherine ;

Ren, Ruibao ;

Rodin, Heather Yeckes ;

Miller, Kenneth ;

Khosravi-Far, Roya .

CANCER RESEARCH, 2009, 69 (16) :6546-6555

[4] The emerging roles of forkhead box (Fox) proteins in cancer [J].

Myatt, Stephen S. ;

Lam, Eric W. -F. .

NATURE REVIEWS CANCER, 2007, 7 (11) :847-859

[5] Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study [J].

Ottmann, Oliver ;

Dombret, Herve ;

Martinelli, Giovanni ;

Simonsson, Bengt ;

Guilhot, Francois ;

Larson, Richard A. ;

Rege-Cambrin, Giovanna ;

Radich, Jerald ;

Hochhaus, Andreas ;

Apanovitch, Anne Marie ;

Gollerkeri, Ashwin ;

Coutre, Steven .

BLOOD, 2007, 110 (07) :2309-2315

[6] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617

← 1 →